Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma
โ Scribed by E. Shelley Hwang; Sarah J. Nyante; Yunn Yi Chen; Dan Moore; Sandy DeVries; James E. Korkola; Laura J. Esserman; Frederic M. Waldman
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 323 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
BACKGROUND
Lobular carcinoma in situ (LCIS) of the breast is considered a marker for an increased risk of carcinoma in both breasts. However, the frequent association of LCIS with invasive lobular carcinoma (ILC) suggests a precursorโproduct relation. The possible genomic relation between synchronous LCIS and ILC was analyzed using the technique of arrayโbased comparative genomic hybridization (CGH).
METHODS
Twentyโfour samples from the University of CaliforniaโSan Francisco pathology archives that contained synchronous LCIS and ILC were identified. Array CGH was performed using random primerโamplified microdissected DNA. Samples were hybridized onto bacterial artificial chromosome arrays composed of approximately 2400 clones. Patterns of alterations within synchronous LCIS and ILC were compared.
RESULTS
A substantial proportion of the genome was altered in samples of both LCIS and ILC. The most frequent alterations were gain of 1q and loss of 16q, both of which usually occurred as wholeโarm changes. Smaller regions of gain and loss were seen on other chromosome arms. Fourteen samples of LCIS were related more to their paired samples of ILC than to any other ILC, as demonstrated by a weighted similarity score.
CONCLUSIONS
LCIS and ILC are neoplastic lesions that demonstrate a range of genomic alterations. In the current study, the genetic relation between synchronous LCIS and ILC suggested clonality in a majority of the paired specimens. These data were consistent with a progression pathway from LCIS to ILC. The authors conclude that LCIS, which is known to be a marker for an environment that is permissive of neoplasia, may itself represent a precursor to invasive carcinoma. Cancer 2004. ยฉ 2004 American Cancer Society.
๐ SIMILAR VOLUMES
Six patients with lobular carcinoma in situ with microinvasion were described in this report. Lobular carcinoma in situ is not known to progress to microinvasive disease. Although this feature is rare, the current understanding that lobular carcinoma in situ is a marker needs to be revised.
Lobular carcinoma in situ (LCIS) of the breast is commonly identified as an incidental finding in breast biopsies performed because of either a mammographic abnormality or a palpable mass. Although long recognized as an entity, the significance and optimal treatment of LCIS remains controversial. In